Pluronic and tetronic copolymers with polyglycolyzed oils as self-emulsifying drug delivery systems.

AAPS PharmSciTech
Marta Fernandez-TarrioAngel Concheiro

Abstract

The potential of poly(ethylene oxide)-poly(propylene oxide) block copolymers Pluronic F127 (PF127) and Tetronic 304 (T304), 904 (T904) and 1307 (T1307) as components of solid self-(micro)emulsifying dosage forms, S(M)EDDS, was evaluated. The dependence of the self-associative properties of Tetronics on pH explained the low ability of the micelles to solubilize griseofulvin at acid pH (sevenfold increase) compared to at alkaline pH (12-fold). Blends of polyglycolyzed glycerides (Labrasol, Labrafac CC, and Labrafil M 1944CS) with each copolymer at two different weight ratios (80:20 and 60:40) were prepared, diluted in water, and characterized in terms of globule size, appearance and griseofulvin solubility. The blends with Labrasol led to microemulsions that are able to increase drug solubility up to 30-fold. SMEDD hard gelatine capsules filled with griseofulvin and Labrasol or Labrasol/copolymer 80:20 showed a remarkable increase in drug solubility and dissolution rate, particularly when T904, T1307 or PF127 was present in the blend. This effect was more remarkable when the volume of the dissolution medium was 200 ml (compared to 900 ml), which can be related to a higher stability of the microemulsion when there is a greater con...Continue Reading

References

Apr 20, 2001·Physical Review. E, Statistical, Nonlinear, and Soft Matter Physics·C PerreurA Lapp
Sep 3, 2002·Advanced Drug Delivery Reviews·Alexander V KabanovValery Yu Alakhov
Mar 20, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·Laetitia OlivieriJean-Louis Grossiord
Mar 18, 2004·The Journal of Pharmacy and Pharmacology·Manisha DevaniDuncan Q M Craig
Mar 23, 2004·Pharmaceutical Research·Robert G Strickley
Apr 15, 2004·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·R Neslihan Gursoy, Simon Benita
May 26, 2004·International Journal of Pharmaceutics·M-H DufresneM Ranger
Jul 6, 2004·Journal of Pharmaceutical Sciences·Anand BalakrishnanJames E Polli
Nov 22, 2005·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ji-Yeon HongChong-Kook Kim
Feb 4, 2006·Colloids and Surfaces. B, Biointerfaces·Nidia Renée Calafato, Guillermo Picó
Mar 11, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Wei WuLi Que
Jul 4, 2006·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Colin W Pouton
Oct 3, 2006·International Journal of Pharmaceutics·Abhijit A Date, M S Nagarsenker
Oct 24, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Mauro SerratoniAshley Clarke
Nov 11, 2006·Pharmaceutical Research·Gilles DumortierJean Claude Chaumeil
Nov 25, 2006·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Carmen Alvarez-LorenzoAngel Concheiro
Dec 16, 2006·Current Pharmaceutical Design·S R Croy, G S Kwon
Jan 2, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Ahmed Abdalla, Karsten Mäder
Jan 16, 2007·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·John Michael NewtonFridrun Podczeck
Feb 7, 2007·Journal of Pharmaceutical Sciences·Flemming S NielsenAnette Müllertz
May 8, 2007·European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V·Diego A Chiappetta, Alejandro Sosnik

❮ Previous
Next ❯

Citations

May 10, 2011·Pharmaceutical Research·Phuong Ha-Lien TranBeom-Jin Lee
Aug 29, 2012·Photochemistry and Photobiology·María C García ViorJosefina Awruch
Nov 19, 2013·Drug Development and Industrial Pharmacy·Nguyen Duc HanhNuttanan Sinchaipanid
May 18, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Bae Young KimKi Dong Park
Apr 20, 2016·Advanced Drug Delivery Reviews·Orlagh M FeeneyChristopher J H Porter
Sep 30, 2016·Drug Delivery·Bappaditya ChatterjeePinaki Sengupta
Mar 9, 2018·International Journal of Molecular Sciences·Ana Rey-Rico, Magali Cucchiarini
Feb 12, 2015·Beilstein Journal of Organic Chemistry·César A EstévezItziar Vélaz
Sep 13, 2008·Langmuir : the ACS Journal of Surfaces and Colloids·Jaime Gonzalez-LopezAngel Concheiro

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Langmuir : the ACS Journal of Surfaces and Colloids
Jaime Gonzalez-LopezAngel Concheiro
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Diego A Chiappetta, Alejandro Sosnik
European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Für Pharmazeutische Verfahrenstechnik E.V
Carmen Alvarez-LorenzoAngel Concheiro
© 2022 Meta ULC. All rights reserved